ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651607 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651607; 2) Community: the network communities that were significantly associated with the response to NSC 651607; 3) Molecule: the relationships between components within communities and NSC 651607; 4) MDR: the compounds that were significantly associated with the NSC 651607.

NSC Compound Enrichment Correlation
NSC 353451 Mitozolomide 0.0459335986102865 0.40152724
NSC 357704 Cyanomorpholinodoxorubicin 0.0459335986102865 0.47990769
NSC 615035 Tetrazolium, 1-(4,5-dimethyl-2-thiazolyl)-2-phenyl-4-(4-pyridyl)-,bromide 0.0459335986102865 0.02761837
NSC 626388 Null 0.0459335986102865 0.51265281
NSC 627759 2'-Phenyl-17a-aza-D-homo-5-androsteno[17,16-c]pyrazol-3.beta.-yl acetate 0.0459335986102865 0.066113453
NSC 670765 Null 0.0459335986102865 0.097832496
NSC 681636 Camptothecin Derivative 0.0459335986102865 0.25147218
NSC 688326 Null 0.0459335986102865 -0.094763911
NSC 690148 Null 0.0459335986102865 0.07775334
NSC 691421 Null 0.0459335986102865 0.31771553
Total:52  Current:44    [First] [Prev] [Next] [Last]